Tag: Health Insurance

Zizzl Health Expands with New Headquarters in Milwaukee

Zizzl Health relocates headquarters to enhance capacity for innovative health benefits solutions, reflecting strategic growth in the insurance industry.

Significant Decline in ACA Enrollment in Ohio

Explore how the end of ACA subsidies has drastically affected enrollment in Ohio and other rural areas, raising concerns about health insurance access and affordability.

Affordable Care Act Health Insurance Market Changes

Explore significant changes in ACA health insurance markets, rising premiums, and the impact of silver loading on premiums and federal regulations.

Significant Premium Increases in Kansas City's Health Insurance Market

Discover expected premium increases for health insurance in Kansas City, with hikes of 10% to 35% due to rising medical costs and claims volume.

Understanding HSA Contributions and Medicare Enrollment for Retirement Planning

Learn about the impact of Medicare Part A on HSA contributions, and avoid financial penalties with informed retirement planning and strategic decisions.

Navigating Medical Debt: Strategies to Alleviate Financial Burdens

Learn viable strategies to alleviate medical debt, including negotiating bills and financial assistance programs for those facing healthcare costs.

The Impact of Medicare on U.S. Healthcare Budget and Population

Explore how Medicare influences the U.S. healthcare budget and demographics. Understand its financial challenges and implications for beneficiaries.

CNO Financial Group Q2 2026 Report: Revenue Ahead of Expectations

CNO Financial Group's Q2 2026 report shows strong revenue growth and strategic positioning in Medicare Supplement and annuities. Find insights and forecasts.

Decline in ACA Enrollment in Ohio After Expiration of Subsidies

Ohio faces a 32% drop in ACA enrollment post-subsidy expiration, highlighting urgent need for affordable health coverage initiatives.

Examining Medicare Part D Cancer Drug Denials: Study Insights

Explore key findings on Medicare Part D cancer drug denials, overturn rates, and the need for improved appeals processes from a recent study.